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Summary
Objectives: : To study synovial membrane (SM) inﬂammation near the patella with different magnetic resonance imaging (MRI) approaches
performed using a T1-injected sequence in knee osteoarthritis (OA), and to compare MRI results with macroscopic, microscopic and clinical
ﬁndings.
Methods: Fifteen patients fulﬁlling American College of Rheumatology (ACR) criteria for knee OA and requiring joint lavage completed a func-
tional index (Lequesne’s functional index) and a pain visual analog scale (VAS). SM inﬂammation near the patella was assessed on axial fat
saturation post-injected T1 MRI images using three different methods: (1) semi-quantitative score¼MRI synovitis score; (2) synovial
membrane volume (SMV) analysis; (3) SMV with low (SMVL) (<0.3%/s1), intermediate (SMVI) (0.3%/s1 to 1%/s1) and high (SMVH)
(1%/s1) speed of enhancement. Chondral lesions and SM inﬂammation were macroscopically graded and SM biopsies performed for
microscopic scoring.
Results: All MRI approaches exhibited excellent intra- and inter-observer reproducibility. MRI synovitis score correlated well with macroscopic
(r¼ 0.61, P¼ 0.003) and total microscopic scores (r¼ 0.55, P¼ 0.03). Correlations between SMV and macroscopic (r¼ 0.60, P¼ 0.02) and
microscopic congestion (r¼ 0.63, P¼ 0.01) were good. SMVH was correlated only with microscopic congestion (r¼ 0.79, P¼ 0.01). Low SMV
was associated with neither macroscopic nor microscopic scores. However, it did correlate well with pain-VAS score (r¼ 0.61, P¼ 0.03) and
moderately with a functional index (r¼ 0.46, P¼ 0.10).
Conclusion: The three MRI approaches used here provided highly reproducible information on SM inﬂammation near the patella in knee OA.
Compared to SMV, MRI synovitis score seems sufﬁcient to assess synovial inﬂammation but high SMV is an appropriate indicator of vascular
congestion, and low SMV reﬂects pain in knee OA.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
Key words: Osteoarthritis, MRI, Synovial membrane inﬂammation.Osteoarthritis (OA), deﬁned by cartilage breakdown and
bone modiﬁcations, is a chronic disease affecting 8e15%
of the populations of developed countries1,2. The presence
of synovitis is usually considered as a secondary event
caused by phagocytosis of cartilage breakdown products
but synovitis may also initiate, and contribute to, chondral
lesions3.
Magnetic resonance imaging (MRI) has revealed little
about the prevalence of synovial abnormalities in knee
OA as most studies have been performed using non-aEqual contribution.
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1186injected images, especially FS T2-weighted images4e7
which do not distinguish inﬂamed synovium from fatty tis-
sue. Nevertheless, these studies have shown the preva-
lence of synovitis to be high, particularly in end-stage
disease6e8. Contrast agents allow for good characterization
of synovium in inﬂammatory diseases as well as in OA9e11.
In knee OA, two recent semi-quantitative scoring studies
performed with post-injected T1 images conﬁrmed the pres-
ence of active synovitis3,12. Synovial biopsies performed in
only one study showed good correlations between MRI
scores and macroscopic and microscopic data3.
In inﬂammatory diseases, synovial membrane volume
(SMV) is highly correlated with local clinical signs of inﬂam-
mation13,14 and histopathologic parameters10,15e17 in
cross-sectional as well as longitudinal studies18e21. SM in-
ﬂammation can also be measured by the speed of en-
hancement after contrast agent administration15,17,22. The
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slice, with fast sequences (total acquisition time less than
20 s) repeated over 10 min, which allows the speed of en-
hancement of the SM at the ROI to be calculated. Results
obtained with this method have shown excellent correlation
with microscopic inﬂammatory parameters15 but are weakly
reproducible.
Here, we report the use of a new MRI technique that
combines SMV measurement and speed of enhancement
of synovial tissue at 186 s in 15 patients suffering from
various stages of knee OA. The volume of synovium is
determined with low, intermediate and high-speed en-
hancement and the results are compared with SMV and
a semi-quantitative score ‘‘the MRI synovitis score’’. The
objective of the work is to study synovial membrane
(SM) inﬂammation with different MRI approaches per-
formed using a T1-injected sequence in knee OA, and
to compare MRI results with macroscopic, microscopic
and clinical ﬁndings.
Patients and methodsPATIENTSMRI was performed in 15 knees of 15 patients (nine women and six men),
fulﬁlling the American College of Rheumatology criteria for knee OA23. Pa-
tients were scheduled to have joint lavage because of the persistence of
pain, chronic joint effusion and/or lack of efﬁcacy of general or local treat-
ments (3 months after corticosteroid or hyaluronate injections on average).
Patients were not recruited at the time of surgery and, then, were more rep-
resentative of the different stages of the disease. Patients with evidence of
crystal-induced disease, traumatic injuries or active inﬂammatory disorders
were excluded. The median age of the patients was 58 years (range
40e76). Written informed consent was obtained from all subjects.ASSESSMENTDemographic data and other characteristics were recorded at baseline.
Functional disability and pain were assessed using Lequesne’s functional in-
dex24 and a pain visual analog scale (VAS). Standard blood tests, including
serum C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR)
were performed just before arthroscopy. X-rays were graded according to
Kellgren and Lawrence25.Fig. 1. The two slices chosen for the MRI synovitis score corresponds to
the patella was still visible. SM inﬂammation was graded according to th
between 0 and 15. 254 1MRI EVALUATIONTechnique
All patients underwent MRI between 1 and 7 days before arthroscopic ex-
amination. Imaging was performed using a 1.5 T scanner (General Electric
Medical Systems, Milwaukee, WI, USA) with a transmit-receive knee coil
to achieve uniform receptivity throughout when the knee was in a neutrally
rotated position. SM was studied on a fast multiplanar spoiled gradient-re-
called acquisition in the steady state T1-weighted sequence (repetition
time 180 ms, echo time 4.2 ms, ﬂip angle 90, ﬁeld of view 12 12 cm, ma-
trix 256 256 pixels, slice thickness (ST) 3 mm, slice gap 0.0 mm and 1 nex)
performed in a transverse plane without contrast agent. With the patient in
the same position, 0.1 mmol/kg of gadolinium-DTPA (Gd-DTPA) (Guerbet,
Aulnay, France) was injected into a cubital vein and the sequence was re-
peated. Total acquisition time for the two sequences was 6 min and 12 s.SYNOVIAL EVALUATIONSM inﬂammation was studied with three different methods on the same
sequence: (1) a validated semi-quantitative score for the measurement of sy-
novial inﬂammation in OA ‘‘MRI synovitis score’’; (2) quantitative measure-
ment of SMV; (3) quantitative measurements of SMV with low-speed
enhancement (SMVL), intermediate-speed enhancement (SMVI) and high-
speed enhancement (SMVH) 186 s after Gd-DTPA injection.
Semi-quantitative measurement: MRI synovitis score
Slices chosen to grade SM inﬂammation corresponded to the ﬁrst and the
last axial slices in which the patella was still visible. SM inﬂammation was in-
vestigated as previously described3 on an axial post-injection T1-weighted
sequence. Brieﬂy, thickening of the inﬂamed SM was determined in ﬁve re-
gions of interest (ROIs) and graded on a four-point scale3 (Fig. 1). The MRI
synovitis score varied between 0 (normal synovial tissue) and 15 (the most
severe and diffuse synovial inﬂammation).
Quantitative measurement of the SMV
SMV13,26 was measured using image-processing software (MATLAB7)
installed on a personal computer (PC). Only those axial slices in which the
patella was visualized were selected for volume analysis. The SM was
outlined on post-injected images using a threshold of enhancement of
45% between injected and non-injected images27 (Figs. 2 and 3). The
non-synovitis regions were removed and the synovitis area was calcu-
lated automatically for each slice. SMV was calculated by summation of
the synovitis areas of all slices using the following formula: SMV¼ S(Ar-
syniST) where ST is the slice thickness and Arsyni is the area of the
SM in slice i.the ﬁrst and the last axial post-injection T1-weighted slices in which
ickening severity in ﬁve ROI (1e5). The MRI synovitis score varied
90 mm (72 72 DPI).
Fig. 2. On axial post-injection T1-weighted slices (B), SM with a threshold of enhancement 45% was outlined (C) and the speed of enhance-
ment was calculated for each voxel and categorized as: low (blue colour) intermediate (green colour), or high speed of enhancement
(red colour) 254 190 mm (72 72 DPI (D)).
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enhancement
Thespeedof enhancementwas calculated for eachpixel of the synovitis area
outlined according to the following formula: (S186S0)/(S0 186) 100,
where signals S186 and S0 were the SM signals at t¼ 186 s and t¼ 0 (before
injection). The SMV was assessed according to its speed of enhancement
and categorized as: (1) low (<0.3%/s1), intermediate (0.3%/s1 but
<1%/s1) or high speed (1%/s1)15,22,28 (Figs. 2 and 3). The volume of each
category and the ratio of SMVH/SMV were also determined.
Magnetic resonance (MR) images were read according to the three differ-
ent approaches by two observers blinded to the patients’ other characteris-
tics. In order to assess inter-observer variability, two observers (ICV and
JCG) conducted all 15 examinations. One observer (JCG) made 15 mea-
surements twice to determine intra-observer reproducibility.CHONDROSCOPIC EXAMINATIONTechnique
Chondroscopy was performed under local anesthesia (lidocaine adrena-
line 2%) by a rheumatologist (DL). A standard knee arthroscope (2.7 mm)
with a 30 fore oblique lens and a wide ﬁeld of view was inserted via the in-
ferior lateral and medial femorotibial portals. Chondroscopic exploration was
combined with joint lavage. All procedures were recorded on VHS videotape
(super VHS Panasonic VS 100H; Panasonic, Matsushita Electronic indus-
trial, Osaka, Japan). At ﬁve regions, three in the suprapatellar recess (lateral
recess, medial recess and just above the trochlear groove) and two in the
medial and lateral femoral gutter: SM macroscopic analysis and SM biop-
sies were performed.EVALUATION OF THE SM (MACROSCOPIC AND MICROSCOPIC
SCORING)The macroscopic appearance of the SM was graded3 and SM biopsy
specimens were obtained when technically possible. SM biopsies wereFig. 3. Only axial post-injection T1-weighted slices in which the patella was
SM with a threshold of enhancement 45% was outlined and the SMV calc
enhancement and categorized as: low (blue colour), intermediate (
254 190 mm (72graded for six parameters and a mean total composite score was calculated
for each specimen3,10.STATISTICAL ANALYSISMRI characteristics of SM inﬂammation were described with medians and
ranges. Spearman correlation coefﬁcients (r) were computed to analyse the
associations between MRI measures and clinical, biological, macroscopic
and microscopic characteristics. An r value lower than 0.3 indicates little or
no association, between 0.3 and 0.7 the association is moderate, and above
0.7 it is strong. For SM macroscopic and microscopic data, the average
grades at the different biopsy sites on the same knee were calculated. To an-
alyse testeretest reliability, the median and range of the absolute and rela-
tive variations between the two observers and between two readings were
calculated. Inter- and intra-observer reliabilities of MRI score or volumes
were assessed with intraclass correlation coefﬁcients (ICC) derived from
a two-way analysis of variance in a random effect model and their 95% con-
ﬁdence intervals (95%CI)29. Testeretest reliability was also studied using the
Bland and Altman graphical method to check whether reliability errors are
homogeneous along the range of score or volume30. Statistical analyses
were performed using Statistical Analysis System version 9.1 for Windows
(SAS institute, Cary, NC, USA).ResultsSAMPLE DESCRIPTIONCharacteristics of the study patients, MRI data, and re-
sults of histological investigation of the SM are summarized
in Table I. Forty synovial biopsies were performed and dis-
tributed as follows: two biopsies by knee (n¼ 7), three bi-
opsies by knee (n¼ 7) and ﬁve biopsies by knee (n¼ 1).
Concerning biopsies localization, 11 were performed in
the suprapatellar lateral recess, 11 in the suprapatellarvisualized were selected for volume analysis (A, B). On each slice,
ulated (C). Finally the SMV was assessed according to its speed of
green colour) or high speed of enhancement (red colour) (D).
 72 DPI).
Table I




Demographic and clinical characteristics
Age 58.0 (40.0e76.0)
Sex, N (%) e men 6 (40)
VAS pain (0e100) 51.0 (7.0e89.0)
Lequesne’s index (0e24) 11.5 (2.0e18.0)
VS (mm/h) 14.0 (1.0e94.0)
CRP (mg/dl) 5.0 (5.0e14.4)






MRI synovitis score (0e15) 8.5 (1.0e13.0)
SMV (mm3) 4606.2 (139.5e20123.7)
SMVL (mm3) 1450.5 (24.7e7053.6)
SMVI (mm3) 2604.8 (69.5e6576.5)
SMVH (mm3) 786.9 (19.7e13289.2)
SMVH/SMV (%) 17.8 (1.7e66.0)
Macroscopic score 2 (1e3)
Microscopic score
Synovial lining cells 2 (1e3)





Total composite score 1.5 (0.3e2.3)
1189Osteoarthritis and Cartilage Vol. 17, No. 9medial recess, three just above the trochlear groove, two in
the medial femoral gutter and 13 in the lateral femoral
gutter.MRI CHARACTERISTICS OF SM INFLAMMATIONIn the total sample, the median MRI synovitis score was
8.5 (range: 1e13) and the median SMV was 4606 mm3
(range: 139e20124) (Table I). The total SMV comprised
21% SMVH, 48% SMVI and 31% SMVL. The ratio SMVH/
SMV was highly variable, ranging from 1 to 66%.TEST-RETEST RELIABILITYThe relative and absolute inter- and intra-observer varia-
tions of the different MRI data are shown in Table II. Inter-
and intra-observer reproducibilities were excellent for the
MRI synovitis score (ICC¼ 0.89; 95%CI [0.70e0.96],
ICC¼ 0.95; 95%CI [0.86e0.99] respectively). Inter- andTable I
Intra- and inter-observer reproducibili
Inter-observer reproducibility
Absolute change % Cha
Median (range) Median
MRI synovitis score 1 (3.0; 2.0) 13.4 (6
SMV 405.6 (1944.3; 24.8) 7.1 (3
SMVL 171.4 (1211.7; 106.9) 13.8 (5
SMVI 152.2 (705.7; 249.6) 6.5 (2
SMVH 28.2 (532.0; 53.4) 4.9 (5
SMVH/SMV 0.3 (3.8; 2.9) 4.9 (1intra-observer reproducibilities were also excellent for
SMV, SMVH, SMVI and SMVL (all ICC 0.98). Reliability
errors of the different volumes measured were homoge-
neous along the range of volumes on the Bland and Altman
graphic analyses.ASSOCIATIONS BETWEEN MRI DATA, AND CLINICAL,
OR HISTOLOGICAL FINDINGSClinical and biological assessment
No correlations betweenMRI measures and age or biolog-
ical data were statistically signiﬁcant. No correlation was
noted between MRI synovitis score or SMV and clinical
data. Only moderate and positive correlations were noted
between SMVL and VAS pain (r¼ 0.61; P< 0.05) or Le-
quesne’s index (r¼ 0.46; P¼ 0.10) (Table III). However, al-
though correlation coefﬁcients did not reach statistical
signiﬁcance, SMVH, SMVI and the SMVH/SMV ratio were
moderately negatively correlatedwith clinical characteristics.
Macroscopic and microscopic assessments
MRI synovitis score was positively correlated with the
macroscopic appearance of SM (r¼ 0.61), and with con-
gestion (r¼ 0.52) and inﬁltration (r¼ 0.54) on microscopic
analysis performed on 40 SM samples (Table III). Not
only SMV and SMVH but also SMVI were correlated with
macroscopic (r¼ 60; 0.48 and 0.57 respectively) and micro-
scopic (r¼ 0.63; 0.79 and 0.61) congestion scores. Con-
versely, SMVL was not statistically correlated with any
macroscopic or microscopic score. The correlation between
SMVH/SMV and microscopic congestion was positive and
statistically signiﬁcant (r¼ 0.63), whereas that between
SMVH/SMV and microscopic inﬁltration, oedema and ﬁbro-
sis were moderate and negative. SMVH and SMVI were
signiﬁcantly higher in knees with severe congestion than
in knees with mild congestion and were signiﬁcantly lower
in knees with severe ﬁbrosis than in knees with mild ﬁbrosis
(data not shown).
Discussion
MRI is known to improve the diagnosis of knee OA when
radiographs are still normal, and can help with follow up of
disease evolution by facilitating precise assessment of car-
tilage lesions and measurement of cartilage volume5,31,32.
However, the role of synovitis on pain and its impact on car-
tilage breakdown is still debated4e7. Moreover, imaging
data in OA are rarely compared to histological data which
can be considered as the gold standard for synovitis. The
aim of this study was to compare three methods of MRI sy-
novitis scoring on post-injected sequence and to compare
the results with clinical and histologic data.I
ty of MRI synovitis assessment
Intra-observer reproducibility
nge Absolute change % Change
(range) Median (range) Median (range)
6.7; 28.6) 0.5 (2; 2) 10 (18.2; 33.3)
2.7; 16.3) 7.3 (253.8; 862.0) 0.1 (3.0; 10.4)
4.5; 13.3) 1.3 (57.3; 382.7) 0.0 (5.5; 17.1)
0.7; 21.2) 4.0 (146.4; 452.9) 0.1 (3.5; 10.1)
1.2; 60.1) 1.3 (56.9; 26.4) 0.4 (5.9; 20.4)
3.9; 64.9) 0.0 (1.7; 1.8) 0.3 (9.6; 12.6)
Table III
















r r r r r r
VAS pain score 0.25 0.09 0.30 0.14 0.61*0.45
Lequesne’s index 0.11 0.27 0.34 0.30 0.46 0.39
ESR 0.50 0.17 0.33 0.15 0.21 0.35
CRP 0.35 0.19 0.04 0.16 0.36 0.10
SM macroscopic
score
0.61* 0.60* 0.48 0.57*0.05 0.28
SM microscopic score
Synovial lining cells 0.16 0.20 0.05 0.25 0.13 0.08
Fibrin deposition 0.35 0.06 0.12 0.10 0.25 0.17
Fibrosis 0.01 0.03 0.30 0.08 0.25 0.37
Oedema 0.01 0.01 0.11 0.00 0.36 0.34
Congestion 0.52* 0.63* 0.79* 0.61* 0.35 0.63*
Inﬁltration 0.54* 0.08 0.16 0.12 0.31 0.34
Total composite
score
0.41 0.00 0.20 0.01 0.44 0.48
*P< 0.05.
1190 D. Loeuille et al.: Synovial membrane and MRI in OAMRI SYNOVITIS SCOREWe conﬁrmed that MRI synovitis score is a simple
method of accurately assessing synovial inﬂammation
near the patella in knee OA, requiring no more than
10 min. The superior ROIs are localized near the femoro-
patellar compartment while the inferior ROIs is positioned
near both femorotibial and femoro-patellar compartments3.
This score is well correlated with macroscopic and total mi-
croscopic scores, congestion and inﬁltration. As already
shown, no correlation was found between this score and
clinical characteristics.SYNOVIAL VOLUME ASSESSMENTSMV is a more sophisticated method requiring 30 min to
accurately assess synovial inﬂammation in knee OA. This
technique has been evaluated mainly in Rheumatoid Arthri-
tis (RA). Similarly to previous studies, synovial volume was
studied in a large ROI localized around the patella. The du-
ration of this injected sequence was 180 s e the optimal
time when measuring SMV, as 5 min after intra-venous in-
jection, gadolinium leaves the synovium (vessels, interstitial
tissue) and diffuses into the synovial ﬂuid33. With regard to
the segmentation procedure used here, SM outlining was
performed with an optimized threshold of enhancement of
45%, as published by Ostergaard27. Thus, we demon-
strated that SMVs are well correlated with macroscopic
and total microscopic scores and particularly with conges-
tion. In comparison to RA the relationships between SMV
and clinical signs of inﬂammation13,21,22 and histopathologic
parameters of synovitis3,10,17,34 were less strong. As for
MRI synovitis score, no relationship was found with clinical
or biological data.VOLUME PLUS SPEED OF ENHANCEMENT OF THE SYNOVIAL
TISSUEWe present here an original method of measuring the
speed of enhancement of the SM and expressing the result
in terms of SMV. SMVL, SMVI and SMVH wereautomatically acquired with SMV measurement (30 min).
So, as previously published in both RA and OA, we applied
three thresholds13,22 based on the speed of SM gadolinium
enhancement: ﬁrst threshold <0.3%/s1, second threshold
0.3%/s1 but <1%/s1; and third threshold 1%/s1 13,27.
The speed of enhancement of the SM was determined not
only for a ROI on a single slice15,22 as previously published
and which usually exhibited poor reproducibility, but for a large
region of SM with excellent intra- and inter-observer
reproducibility.
As for SMV, we measured large ranges of SMVH, SMVI
and SMVL. As previously demonstrated by Ostergaard
et al., the correlation between SMVH and congestion was
excellent; however, surprisingly, inverse correlations were
found with inﬁltration, synovial lining cells, ﬁbrosis, ﬁbrin de-
posits, and oedema10. Thus, SMVH seems to be a reliable
means of quantifying vascularization in SM and evaluating
therapeutic response.
Concerning SMVL, no correlation was found with either
macroscopic score or microscopic parameters. However,
we demonstrated for the ﬁrst time a moderate positive cor-
relation between SMVL and VAS pain and Lequesne’s in-
dex. The relationship does not seem related to
inﬂammatory or a ﬁbrotic pattern, this last parameter being
usually linked with disease evolution and joint damage35.
So, a low level of SM inﬂammation, without any remarkable
microscopic pattern, should be responsible for pain in knee
OA. This result could be due to multiple testing, and should
be conﬁrmed by a study with a larger sample before adding
SMVL to the list of joint features associated with pain in
knee OA, such as: bone marrow lesions36e38, subchondral
attrition39 and periarticular lesions40.LIMITSOne limit of this study relates to the use of classic fast
multiplanar spoiled gradient-recalled acquisition in the
steady state T1-weighted sequence. This restricts the ac-
quisition time to 186 s when it could be less with a fast
short imaging sequence or single slice acquisition. Thus,
the optimal ‘‘time window’’ of 55 s, classically used to eval-
uate synovitis in RA was not possible15. This can result in
an over or underestimation of the rate of enhancement de-
pending on the shape of the enhancement curve. More-
over, SVM was not calculated for the entire knee but
only for the region surrounding the patella. The cross-sec-
tional nature of the study does not allow studying the
causal relationships of synovitis and chondral lesions and
patient symptoms. This question was not under the scope
of this work but should be explored in future studies. Fi-
nally, the results of this study cannot be generalized to
all subjects with knee OA as our sample included patients
scheduled to have joint lavage because of the persistence
of pain and effusion and lack of efﬁcacy of other
treatments.
Conclusion
We demonstrate that both SMV and MRI synovitis score
are highly reproducible techniques, but the latter is less
time-consuming. As previously published, MRI synovitis
score is well correlated with microscopic parameters, espe-
cially inﬁltration score. In comparison to MRI synovitis
score, SMV is a time-consuming technique and correla-
tions with microscopic parameters are not improved, ex-
cept for congestion. As expected, SMVH is highly
correlated with vascular congestion but not with clinical
1191Osteoarthritis and Cartilage Vol. 17, No. 9and biological data. We have shown, for the ﬁrst time, that
pain and loss of function may be related to SMVL, which
was not associated with any notable microscopic features
but this data should be conﬁrmed on a larger sample.
We expect that, in future studies, the various MRI methods
described here, will provide information about the impact of
synovitis on cartilage breakdown, and help accurately as-
sess the impact of drugs on SM inﬂammation, particularly
congestion.Conﬂict of interest
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